GRANISOL Drug Patent Profile
✉ Email this page to a colleague
When do Granisol patents expire, and what generic alternatives are available?
Granisol is a drug marketed by Intra Sana Labs and is included in one NDA.
The generic ingredient in GRANISOL is granisetron hydrochloride. There are twenty-six drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the granisetron hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Granisol
A generic version of GRANISOL was approved as granisetron hydrochloride by AMNEAL on December 31st, 2007.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for GRANISOL?
- What are the global sales for GRANISOL?
- What is Average Wholesale Price for GRANISOL?
Summary for GRANISOL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 41 |
| Clinical Trials: | 4 |
| Patent Applications: | 1,343 |
| DailyMed Link: | GRANISOL at DailyMed |
Recent Clinical Trials for GRANISOL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Tesaro, Inc. | Phase 3 |
| University of Miami | Phase 2 |
US Patents and Regulatory Information for GRANISOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intra Sana Labs | GRANISOL | granisetron hydrochloride | SOLUTION;ORAL | 078334-001 | Feb 28, 2008 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
